Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💻 Telehealth

Location

India

Market Cap

USD 12.62 B

Share Price

USD 37.30

Avg Daily Volume

343,112

Change (1 day)

0.79%

Change (1 year)

10.06%

Change (YTD)

-4.97%

Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2025: 49.86%

Torrent Pharmaceuticals Limited Gross Profit Margin is 49.86% for the year ending March 31, 2025, a 13.09% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2024 was 44.09%, a -37.99% change year over year.
Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2023 was 71.10%, a 1.78% change year over year.
Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2022 was 69.86%, a -2.51% change year over year.
Torrent Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2021 was 71.66%, a 0.86% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Gross Profit Margin	EBIT Margin	EBITDA Margin	Net Income Margin

NSE: TORNTPHARM.NS

Torrent Pharmaceuticals Limited

CEO	Mr. Sanjay Gupta
IPO Date	July 1, 2002
Location	India
Headquarters	Torrent House
Employees	15,718
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 💻 Telehealth

Description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.